In parts of China, rates of a respiratory disease called human metapneumovirus (HMPV) are surging, leading to some concerns about whether a more serious outbreak could occur. Here's what you need to know about HMPV and its potential impact in the United States.
HMPV is a respiratory virus similar to respiratory syncytial virus (RSV). Although HMPV was first identified in 2001, researchers say it has circulated in humans for at least 60 years.
"It's oftentimes indistinguishable from the other respiratory viruses, because we don't usually check for it unless somebody is really ill," said Peter Chin-Hong, a professor of medicine and an infectious diseases specialist at the University of California, San Francisco.
Some symptoms of HMPV include cough, fever, sore throat, nasal congestion, and shortness of breath.
While most cases of HMPV are mild, it can lead to bronchitis and pneumonia in severe cases, particularly in young children, older adults, and those with weakened immune systems.
Currently, cases of HMPV are surging in China, especially in the country's northern region. According to data from China, rates of HMPV, including both outpatient and emergency cases, have been increasing in the country since mid-December.
Although there have been some concerns about a potential health crisis involving HMPV, Chinese authorities have said that the virus is a known pathogen and not a major concern. And while rates of respiratory viruses are currently increasing in the country, a spokesperson for China's Foreign Ministry said that the viruses "appear to be less severe and spread on a smaller scale compared with the year before."
Aside from China, HMPV has been detected in India, Malaysia, and the United Kingdom. In the United States, CDC data shows that 1.94% of weekly tests for HMPV were positive as of Dec. 28. At the same time, weekly positivity rates for flu and COVID-19 were 18.71% and 7.1%, respectively.
In a statement, CDC said it is "monitoring reports of increased disease" in China as the country deals with the surge in HMPV cases. However, the agency noted that these reports are "not currently a cause for concern in the U.S."
Similarly, the World Health Organization (WHO) has not expressed any concerns about the rise in HMPV cases in China, saying that the increase is expected during the respiratory virus season. "As expected for this time of year, the Northern Hemisphere winter, there is a month-over-month increase of acute respiratory infections, including seasonal influenza, R.S.V. and human metapneumovirus," said Margaret Harris, a WHO spokesperson.
"China is experiencing a large outbreak of human metapneumovirus (HMPV) cases at the moment. Although this is a priority for China's health system, it should not lead to immediate concerns about a new pandemic," said Sanjaya Senanayake, a specialist in infectious diseases at the Australian National University.
Currently, there is no vaccine to prevent HMPV, but common prevention methods include practicing good hand hygiene, covering your nose and mouth when coughing or sneezing, and staying home if you're sick.
Health experts also say that it's important to be vaccinated against other respiratory diseases, such as COVID-19, flu, and RSV, to reduce the risk of coinfection.
"Sure, you can get serious disease from HMPV itself, but if you get HMPV plus pneumococcus or HMPV plus influenza or RSV, it could be much worse," Chin-Hong said. "During respiratory virus season, you want to minimize the probability of co-infection."
(Nolen, New York Times, 1/7; Bettelheim, Axios, 1/7; Chiappa, Politico, 1/6; Kekatos, ABC News, 1/6; Ng, BBC, 1/7)
Create your free account to access 1 resource, including the latest research and webinars.
You have 1 free members-only resource remaining this month.
1 free members-only resources remaining
1 free members-only resources remaining
Never miss out on the latest innovative health care content tailored to you.